Client News

VisionHealth receives EU Medical Device Regulation certification

MagForce AG: Enrollment in Stage 2b of Pivotal U.S. Study for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System successfully underway following IRB approval

invIOs goes live with unique cell therapy platform and clinical-stage immuno-oncology pipeline

Patronus Health GmbH Receives Angel Investment and Public Grant

sterna biologicals announces dosing of first patient in phase IIa proof-of-concept study with SB010 in moderate to severe asthma

Marinomed and Friedrich-Alexander-Universität Erlangen-Nürnberg publish new data on antiviral efficacy of iota-carrageenan against SARS-CoV-2 variants of concern

Apogenix Receives EUR 20.7 Million in Public Funding for Pivotal Study and Preparation for Market Production of Asunercept for the Treatment of COVID-19

RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations

Atriva Therapeutics strengthens advisory board with Piet Wigerinck

Newron Pharmaceuticals S.p.A.: Change in Newron Board of Directors